A number of studies aimed to advance the molecular profiling capabilities in aggressive B-cell lymphoma were presented at the 62nd ASH Annual Meeti......READ MORE
At the 62nd ASH Annual Meeting and Exposition, a number of abstracts focused on strategies to optimize chimeric antigen receptor (CAR) T-cell thera......READ MORE
Several abstracts presented at the 62nd ASH Annual Meeting and Exposition focused on cellular immunotherapy for relapsed aggressive B-cell lymphoma......READ MORE
At the 62nd ASH Annual Meeting and Exposition, researchers described varying strategies to address unmet needs in the treatment of aggressive B-cel......READ MORE
Several abstracts presented at the 62nd ASH Annual Meeting and Exposition focused on novel and emerging treatment approaches in aggressive B-cell l......READ MORE
Several abstracts presented at the 62nd ASH Annual Meeting and Exposition focused on treatments for patients with high-risk variants of aggressive ......READ MORE